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Objective: The diagnosis of extrapulmonary tuberculosis is still a challenge because of its
pauci-bacillary nature. The aim of the study was to evaluate the role of a multiplex PCR
assay in the diagnosis of extrapulmonary tuberculosis and to compare the efﬁciency of two
targets, IS6110 and MPB64 to detect Mycobacterium tuberculosis.
Methods: 150 extrapulmonary samples (61 pus/aspirate, 46 tissue, 32 body ﬂuids, and 11
urine) from clinically suspected cases of tuberculosis were included in the study. All
the  samples were subjected to direct ﬂuorescent microscopy, TB culture (BacT/ALERT 3D,
biomerieux, Durham, North Carolina, USA) and a Multiplexed Tandem PCR targeting two
mycobacterial DNA sequences, IS6110 and MPB64. Master-Mix reagents and primers were
prepared by AusDiagnostics Pvt. Ltd (Alexandria, New South Wales, Australia). The perfor-
mance of the assay was assessed using a composite gold standard, which included clinical
characteristics, microbiology smear as well as culture, histopathology, cytology, radiology,
and  response to antitubercular therapy.
Results: 20.3%, 23.6%, and 45.3% of specimens were positive by smear, culture, and PCR,
respectively. The sensitivity and speciﬁcity of the multiplex PCR was 91.9% and 88.4%,
respectively, using the composite gold standard. Positive and negative predictive values of
the  PCR were estimated as 85.1% and 93.8%, respectively. Higher positivity was observed with
target IS6110 (44.6%) as compared to target MPB64 (18.9%). The sensitivities of IS6110 and
MPB64 individual targets were 90.3% and 64.5%, respectively, and speciﬁcities were 88.4%
and  97.7%, respectively.Conclusion: PCR can play an important role in rapid and accurate diagnosis of extrapul-
monary tuberculosis. IS6110 alone is an effective target in our part of the country.
er Ed
tuberculosis (EPTB) constitutes around 20% of all TB cases©  2016 Elsevi
ntroductionndia is a high tuberculosis (TB) burden country contributing to
6% of the global burden of the disease. While pulmonary TB
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(PTB) is the most common form of disease, extrapulmonaryin India.1 Early diagnosis is essential in instituting effective
and timely therapy. Conventional methods like smear and cul-
ture are of limited use in diagnosis of EPTB cases due to low
 under the CC BY-NC-ND license. (http://creativecommons.org/
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sensitivity. Ampliﬁcation techniques have attracted consider-
able interest in the diagnosis of tuberculosis particularly with
the hope of shortening the time required in detection. Most
of the assays are evaluated for pulmonary specimens and
smear positive specimens. The diagnosis of extrapulmonary
and smear negative tuberculosis is still a challenge espe-
cially because of the pauci-bacillary nature. Despite numerous
reports in literature, ampliﬁcation techniques do not yet have
an established role in the laboratory diagnosis of tuberculosis,
nor have they replaced traditional techniques. Some stud-
ies have evaluated the role of PCR in the diagnosis of EPTB
using various primers to amplify different targets.2–4 Highly
conserved insertion sequences, IS6110, is the most commonly
used target in the detection of Mycobacterium tuberculosis. Few
Indian studies have pointed out that the most commonly used
method targeting insertion sequence IS6110 has a danger of
missing at least 10% of Indian tuberculosis patients harbor-
ing zero copy number of IS6110.5 Therefore, there is a need
to know which other targets can be used to reliably detect the
EPTB cases. The other candidate target used by the researchers
in India has been the gene encoding mpt64 (MPB64), a sec-
retary mycobacterial antigen present only in M.  tuberculosis
complex, for the diagnosis of TB.6,7 In the present study the
comparative value of a multiplex PCR system which simul-
taneously ampliﬁes two targets, for their role in the early
detection of EPTB has been analyzed using a multiplex real-
time PCR targeting IS6110 and MPB64. Keeping in view the
poor rate of culture positivity in EPTB which makes it dif-
ﬁcult to evaluate assays when it is considered as the gold
standard, we  have also made an attempt to evaluate this
multiplex PCR using a composite gold standard (CGS) based
on clinical presentation along with radiology, histopathology,
and response to anti-tuberculous therapy. Further, the present
study undertook to evaluate the role of a multiplex real-time
PCR assay in the laboratory diagnosis of EPTB in compari-
son to conventional bacteriological techniques like smear and
culture.
Material  and  methods
Patient  population  and  specimens  analyzed
The study was conducted during a period of one year from
April 2012 to March 2013. A total of 150 biological specimens
were collected from patients with a clinical diagnosis of EPTB,
and 20 negative control biological specimens were collected
from patients with an alternative diagnosis. The details of the
specimens analyzed are given in Table 1.
Table 1 – Clinical specimens and negative controls
included in the study.
Type of sample Clinical specimens
(n = 150)
Negative
control (n = 20)
Pus/aspirate 61 5
Tissue 46 5
Body ﬂuid 32 5
Urine 11 5 1 6;2  0(3):235–241
Sample  processing
All the samples were subjected to Direct Fluorescence staining
(DF), mycobacterial culture, and multiplex PCR assay. Patient
demographics were collected from the case ﬁles as well as with
the help of respective clinicians.
The diagnosis of tuberculosis was made on the basis of
a CGS which included clinical characteristics, microbiology
smear as well as culture, histopathology, cytology, radiology,
and response to antitubercular therapy. A case was considered
true positive if culture was positive or any two  of the other
criteria mentioned in the CGS.
DF staining was done using Auramine-Rhodamine
(Sigma/Himedia) staining and examined using ﬂuores-
cent microscope.8 For mycobacterial culture, urine and tissue
samples were subjected to digestion and decontamination
by N-acetyl-l-cystine NaOH (NALC-NaOH) method.9 Other
samples from sterile sites were subjected to decontamination
only if a Gram stain or routine bacterial culture showed the
presence of any organism, otherwise were processed directly.
All the samples were subjected to culture by BacT/ALERT 3D
(biomerieux, Durham, North Carolina, USA) and LJ media as
per the standard protocol.10
Identiﬁcation  of  mycobacteria
Positive growth in either media was identiﬁed as M. tubercu-
losis (MTB) using AccuProbe molecular identiﬁcation system
(GenProbe, San Diego, California).9 AccuProbe culture identiﬁ-
cation test was performed as described by the manufacturer.
For the identiﬁcation of non-tuberculous mycobacteria (NTM),
GenoType Mycobacteria CM (Hain Lifescience GmbH, Nehren,
Germany) was used as recommended by the manufacturer.11
The assay permits the simultaneous molecular genetic iden-
tiﬁcation of the M. tuberculosis complex and 14 of the most
common NTM species (M. avium ssp., M.  chelonae, M.  abscessus,
M. fortuitum, M.  gordonae, M.  intracellulare, M. scrofulaceum, M.
interjectum, M.  kansasii, M.  malmoense, M.  peregrinum, M.  mar-
inum/M. ulcerans, and M.  xenopi)  from cultivated samples.
Real  time  multiplex  PCR
Standardization  of  PCR
Validation of the real time PCR was done using known positive
and negative samples as well as the ATCC standard strain H37
Rv spiked samples. For detection of the analytical sensitivity
of the assay, H37 Rv strain was subjected to PCR using both tar-
gets (IS6110 and MPB64) in different dilutions. 0.5 McFarland
standard was prepared and was serially diluted to achieve dif-
ferent concentrations as 108, 107, 106, 105, 104, 103, 102, and
101 bacilli/mL of the sample. Multiplex real-time PCR was run
using different dilutions of H37 Rv spiked samples, three times
using each dilution.
DNA  extraction
Samples after subjecting to decontamination by NALC/NaOH
method, the DNA extraction was done using spin column
method using DNASure Tissue Mini Kit (Nucleopore, G Brand,
Genetix Biotech Asia Pvt. Ltd., New Delhi, India) as per the
manufacturer’s instructions. Brieﬂy, 25 mg  of tissue or 1–2 mL
of other samples were placed in a microcentrifuge tube.
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80 L of lysis buffer and 25 L of proteinase K solutions were
dded and vortexed. Incubated at 56 ◦C for 1–3 h, vortexing
n between till complete lysis of the sample was obtained.
00 L of lysis buffer 3 was added, vortexed and incubated at
0 ◦C for 10 min. If insoluble particles were visible, centrifuged
or 5 min  at 11,000 × g and transferred the supernatant to a
resh microcentrifuge tube. 210 L of absolute ethanol was
dded and vortexed vigorously. For each sample, one DNA-
ure mini kit column was placed into a collection tube and
he sample was applied to the column. Centrifuged for 1 min  at
1,000 × g and discarded the ﬂow-through and placed the col-
mn  back into the collection tube. Washed using wash buffer
wice and discarded the ﬂow-through. Placed the column into
.5 mL  microcentrifuge tube and added 100 L prewarmed
uffer (70 ◦C), incubated at room temperature for 1 min  and
entrifuged at 11,000 × g for 1 min. The extracted DNA was
tored at −70◦ C till the test was performed.
CR  protocol
mpliﬁcation of gene targets was done using Multiplexed Tan-
em PCR employing two sequential PCR steps automated by
he Easy-PlexTM system (AusDiagnostics Ptv. Ltd., Alexandria,
ew South Wales, Australia) targeting two mycobacterial DNA
equences, IS6110 and MPB  64, and also Nono human refer-
nce gene for DNA extraction control and Spike target for PCR
nhibitor control. The Step 2 PCR reaction was performed in
otor-Gene 6000 (Qiagen, Germany) thermal cycler. The prod-
ct from Step 1 was used for real time PCR reactions in Step
 using primers ‘nested inside’ the primers used for Step 1, to
ncrease the sensitivity and speciﬁcity of the assay, by funda-
entally blocking non-speciﬁc priming.
Master-Mix reagents and 72-well gene discs containing
yophilized primers were prepared by AusDiagnostics Pvt. Ltd.
Alexandria, New South Wales, Australia). The M.  tuberculo-
is speciﬁc IS6110 and MPB  64 gene loci were used to design
rimers. 10 L of the puriﬁed DNA was used directly for PCR.
irst-round multiplexed preampliﬁcation was performed in
 20 L reaction volume. Step 1 is a short (18 cycles) multi-
lexed pre-ampliﬁcation reaction using primers homologous
o all targets, IS6110, MPB64, Nono; human reference gene and
pike; PCR inhibitor control. 18 cycles were performed, dena-
uration of ds DNA at 95 ◦C, annealing of primers at 60 ◦C and
xtension at 72 ◦C. Dilution of PCR amplicons (product from
tep 1) was done by biorobot in a plate placed in Easyplex
ystem. Diluted amplicons were added in 72-well Easy-PlexTM
ing containing primers for individual targets. The ampliﬁca-
ion of each target individually in separate wells, in the step 2
f PCR, helped us improving the sensitivity and speciﬁcity of
he assay. This 72 well gene disc was sealed in heat sealer and
laced in Rotor gene. Real time ampliﬁcation was performed
n a RotorGene thermal cycler RG6000 using primers ‘nested
nside’ the primers used for Step 1. The thermal cycling con-
itions were 95 ◦C for 10 min  followed by 30 cycles of 95 ◦C for
5 s, 60 ◦C for 15 s, and 72 ◦C for 15 s. DNA ampliﬁcation is mea-
ured by the increase in ﬂuorescence when Eva-GreenTM dye
as incorporated into the DNA being formed in the speciﬁc
mpliﬁcation reaction.
Presence of either of the sequences was considered as a
ositive result and a comparison between the two targets was6;2 0(3):235–241 237
also done. Comparative sensitivity for detection of M.  tubercu-
losis was also done for these two sequences.
Quality  control
The PCRs were monitored for inhibition by the inclusion of an
internal positive control (Spike; consisting of artiﬁcial DNA)
with each specimen. For extraction procedure, human refer-
ence gene, Nono was used as the system control. Tests were
also monitored for contamination using water as a negative
control in each test run. Each PCR run included ATCC standard
M. tuberculosis strain H37 Rv as positive control.
Statistical  analysis
Sensitivity, speciﬁcity, positive and negative predictive values
of the multiplex PCR as well as that of individual tar-
gets (IS6110 and MPB64) were calculated against the CGS.
The signiﬁcance of difference was determined by proportion
test; probability value of 0.05 was taken as signiﬁcant value
(p < 0.05).
Ethics  approval
Study was approved by the hospital ethics commit-
tee (reference number EC/11/11/313 and approval letter
dated 29/11/2011). Consent was waived since this was an
anonymized study on samples submitted to mycobacteriology
laboratory for diagnosis of TB.
Results
Standardization  of  real  time  PCR
Validation of the real time PCR was done using known positive
and negative samples as well as the ATCC standard strain H37
Rv spiked samples. Both the targets IS6110 as well as MPB64
were detected in all dilutions in all the 3 repeat runs. Analyti-
cal sensitivity of the real time multiplex PCR was found to be
as low as 10 bacteria/mL of the sample. Cycling and melting
curves of the multiplex PCR are shown in Fig. 1.
Smear  and  culture  results
Out of the total 150 extrapulmonary samples included in the
study, two samples failed the extraction of DNA and were
excluded from the analysis. 30/148 (20.3%) specimens were
positive by DF staining. 35/148 (23.6%) specimens were cul-
ture positive for M.  tuberculosis. The average time to detection
for culture positive samples was 23.6 days
Real  time  PCR  results
Out of the 148 samples subjected to PCR test, 67 (45.3%)
were positive and 81 (54.7%) were negative by PCR. Details
are provided in Table 2. Out of the 67 PCR positive samples,
41 were microbiology conﬁrmed, 16 were histopathol-
ogy/clinical/radiology positive and 10 samples were negative
by all other tests. Among 81 PCR negative samples, ﬁve were
238  b r a z j i n f e c t d i s . 2 0
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Fig. 1 – Cycling and melting curves of the multiplex-PCR.
Table 2 – Multiplex PCR results in extrapulmonary tuberculosis
tuberculosis.
Sample type PCR positive, n = 67 (45.3%) 
Microbiology
smear/culture
positive
Microbiology negative,
histopathology/clinical/
radiology positive
All 
Body ﬂuid (n = 30) 4 4 3
Tissue (n = 46) 12 5 4
Pus/aspirate (n = 61) 25 6 3
Urine (n = 11) 0 1 0
Total (n = 148) 41 (61.2%) 16 (23.9%) 10
PCR, polymerase chain reaction; NTM, nontuberculous mycobacteria.
a Smear positive, grew NTM on culture.
b 4 pus samples out of 23 had grown NTM on culture.
Table 3 – Comparison of smear & culture in PCR positive sampl
Sample type Only smear
positive
Only culture
positive
Body ﬂuid 3 
Tissue 2 6 
Pus/Aspirate 8 4 
Urine 0 0 
Total 10 (14.9%) 13 (19.4%) 
PCR, polymerase chain reaction. 1 6;2  0(3):235–241
positive using the CGS (four were microbiology positive & one
histopathology/clinical/radiology positive), and 74 were nega-
tive by all the other tests (Table 2).
Out of the, six microbiologically positive and PCR nega-
tive samples (Table 2), two smear positives subsequently grew
NTM and the remaining four samples were only culture pos-
itive for MTB. These two samples that grew NTM on culture
were treated as microbiologically negative (since they did not
grow MTB), while calculating sensitivity and speciﬁcity of
the PCR. The sensitivity and speciﬁcity of the multiplex PCR
obtained was 91.9% and 88.4%, respectively, when CGS was
used as the gold standard. The positive and negative predictive
values of the multiplex PCR (using both the targets) were esti-
mated as 85.1% and 93.8%, respectively. However, when the 20
control samples were used to assess the negative predicative
value, it was found to be 100%. When the assay performance
was analyzed for different samples, the sensitivity varied from
88.9% for body ﬂuids, 91.2% for pus/aspirate samples to 94.4%
for tissue samples. The speciﬁcity of the assay varied between
85.2% for tissue, 85.7% for body ﬂuids to 88.5% for pus/aspirate
samples. Even though the test was 100% sensitive and speciﬁc
for urine samples, the sample size was too small for interpre-
tation.
Results of smear and culture in 67 PCR positive samples are
given in Table 3. Ten culture negative samples were positive
by smear as well as by PCR (Table 3). Six out of these were
already on ATT for a period varying from one to ﬁve weeks,
which might have affected the culture results but appear to
have not affected the molecular test.
 in comparison to other modalities of diagnosing
PCR Negative, n = 81 (54.7%)
negative Microbiology
smear/cuture
positive
Microbiology negative,
histopathology/clinical/
radiology positive
All neg
 1 0 18
 1a 1 23
 3 + 1a 0 23b
 0 0 10
(14.9%) 6 (7.4%) 1 (1.2%) 74 (91.4%)
es (n = 67).
Both  smear &
culture positive
Both smear &
culture negative
1 7
4 9
13 9
0 1
18 (26.9%) 26 (38.8%)
b r a z j i n f e c t d i s . 2 0 1 6;2 0(3):235–241 239
Table 4 – Comparison of the two targets (IS6110 &
MPB64) in detecting M.  tuberculosis in multiplex PCR
(n = 67).
Sample type Only IS6110
positive
Only MPB64
positive
Both IS6110 &
MPB64
positive
Body ﬂuid 8 0 3
Tissue 9 0 12
Pus/Aspirate 10 1 23
Urine 0 0 1
t
s
m
s
s
s
t
i
s
b
(
r
t
p
t
6
t
h
M
n
a
w
n
t
D
T
I
E
s
P
a
t
a
t
M
u
y
1
P
p
Table 5 – CGS negative, but PCR positive samples (n = 10).
Sample type (no. of
samples)
Signiﬁcant
clinical/laboratory ﬁndings
Pleural ﬂuid (2) Pleural effusion
CSF (1) SLE patient on steroids
Tissue – peritoneum (1) Peritoneal adhesions
Tissue – pleural (1) Empyema
Tissue – rectal (1) Rectal ﬁstula, histopathologically:
nonspeciﬁc acute colitis
Tissue – nasal (1) Histopathologically: Inﬂammatory
nasal polyp
Aspirate (1) Nonspeciﬁc arthritis
Pus (2) 1) Pyoneprosis, isolated E. coli on
routine bacterial culture
2) On cytopathology of
submandibular lymph node
revealed sialadenitis with reactive
lymphadenopathy.Total 27 (40.3%) 1 (1.5%) 39 (58.2%)
Out of 148 samples investigated, six samples grew NTM,
wo smear positive and four smear negative. All these six
amples which grew NTM on culture were considered as
icrobiologically negative samples since the focus of the
tudy was MTB.  Among the two smear positives, one tissue
ample (lymph node biopsy) grew M. avium and the other pus
ample grew M. abscessus.  The remaining four smear nega-
ive samples, which grew NTM, were pus samples and were
dentiﬁed as M.  fortuitum (1) and M. abscessus (3). All these six
amples were PCR negative for both targets.
Among the 67 PCR positive samples, 39 were positive for
oth targets, 27 only for IS6110 and one sample only for MPB64
Table 4). Out of the 148 samples analyzed, more  positive
esults were observed with target IS6110 (44.6%) as compared
o target MPB64 (18.9%). Only one sample out of 148 (0.68%) was
ositive only for MPB64 and was negative for IS6110. The sensi-
ivities of individual targets IS6110 and MPB64 were 90.3% and
4.5%, respectively, and speciﬁcities 88.4% and 97.7%, respec-
ively, in comparison to the CGS. While IS6110 was found to
ave much higher sensitivity as compared to MPB64 (p < 0.001),
PB64 had better speciﬁcity (p < 0.05).
There were 10 out of 67 PCR positive samples that were
egative according to the CGS. The details of these samples
re given in Table 4. All 20 negative controls from patients
ith no clinical suspicion of tuberculosis and with an alter-
ative diagnosis were negative by multiplex PCR using both
argets.
iscussion
B remains a major global public health problem, especially in
ndia. Still worse is the fact that the diagnostic tools to detect
PTB are not sensitive enough to aid in the early detection of
uch cases. The clinical utility of detecting M.  tuberculosis by
CR depends on its rapidity and accuracy in diagnosing EPTB
nd has been evaluated in the current study. We  have analyzed
he accuracy of the PCR assay in the diagnosis of EPTB using
 CGS and have also analyzed the comparative efﬁciency of
wo commonly used PCR targets in India, namely IS6110 and
PB64.
The role of PCR in the diagnosis of EPTB has been eval-
ated previously as an alternative diagnostic tool and has
ielded variable results with sensitivities ranging from 42 to
00% and speciﬁcities ranging from 85 to 100% using various
CR targets such as IS6110, MPB64, TRC4, GCRS, etc.12–14 The
resent multiplex PCR targeting IS6110 and MPB64 seems to bePCR, polymerase chain reaction; CGS, composite gold standard.
promising with a good sensitivity and speciﬁcity of 91.9% and
88.1%, respectively, when CGS was taken as the gold standard.
Whereas smear and culture were positive in 47 out of the total
62 cases using the CGS, PCR detected 57/62 positive cases.
Thereby 10 additional cases which could have gone unde-
tected by conventional microbiologic methods were detected
by PCR. Few recent studies also concluded PCR to be a rapid
and sensitive method for diagnosing EPTB compared to con-
ventional microbiologic methods.15,16 In an earlier study by us
it was observed that the positivity rate of mycobacterial cul-
ture was only 13.6% in extrapulmonary samples in contrast to
18.9% in pulmonary samples.17
However, other 10 doubtful cases were also detected as pos-
itive by PCR out of the 84 cases classiﬁed as negative using
the CGS criteria (Table 5). These were only clinically suspected
cases, but none of the other parameters turned out positive,
other than PCR which resulted in lower speciﬁcity of multiplex
PCR to 88.4%. For these cases, it was not possible to ascertain
whether these were true cases of tuberculosis. However, all the
20 negative control samples from patients with no risk factors
for tuberculosis (true negative controls) were negative by mul-
tiplex PCR giving 100% speciﬁcity to the assay. Moreover, all six
study samples which grew NTM on culture were also negative
by PCR.
Among the six PCR negative and microbiologically positive
samples, two were smear positive and grew NTM on culture
(Table 2). The remaining four samples which grew M. tuber-
culosis, two samples seemed to have very low bacterial load
because the culture came out positive after 38 days and 40 days
of incubation. In the remaining two samples, one each of CSF
and lymph node aspirate, where cultures came out positive
within 20–30 days but PCR remained negative.
In addition to the improvement in the diagnosis of EPTB
using PCR, data on comparison of commonly used PCR tar-
gets in India is also needed. The results of the present study
shows that IS6110 with a sensitivity of 90.3% is a better tar-
get for ampliﬁcation of DNA from extrapulmonary samples
compared to MPB64 with a sensitivity of 64.5% (p < 0.001).
Few previous studies also documented increased positivity of
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IS6110 target in extrapulmonary samples compared to other
commonly used PCR targets.18,19 Negi et al. analyzed various
targets speciﬁc for M.  tuberculosis and reported the highest
PCR positivity rates when IS6110 was used, but MPB64 was
not a target included in their study.18 In our study, out of the
148 samples analyzed, only one sample was IS6110 negative
and MPB64 positive. The absence of IS6110 copies in Indian M.
tuberculosis strains, as observed by some earlier studies was
not very evident in our study. A study by Singh et al. on lymph
node biopsy samples also showed IS6110 (69.1%) as a bet-
ter single target compared to MPB64 (48.2%).20 In their study,
while only IS6110 was positive in 24/81 (29.6%) cases, addi-
tion of MPB64 detected 7/81 (8.6%) additional cases. Therese
et al. in Tamil Nadu concluded that simultaneous use of both
targets, IS6110 and MPB64, together on clinical specimens
(mostly respiratory specimens) could attain 100% sensitivity in
culture proven cases.21 Addition of MPB64 detected only addi-
tional 1.4% of the cases in their study. In a study by Sharma
et al. the positivity rates of Ziehl-Neelsen smear, culture, and
multiplex PCR were 30%, 26.3%, and 91.3%, respectively, in
conﬁrmed tubercular lymphadenitis patients.22 This study
showed MPB64 (87.5%) as a superior target than IS6110 (85%)
in contrast to our study. In our experience, only 1/148 samples
(0.68%) was positive by MPB64 and negative by IS6110. How-
ever, MPB64 as a single target had a higher speciﬁcity (97.7%)
than IS6110 as a single target (88.4%) when CGS was taken as
the gold standard (p < 0.05).
A recent meta-analysis on Xpert MTB/RIF assay (Cepheid,
Sunnyvale, CA, USA) where rpoB gene is the target for the diag-
nosis of EPTB has come up with a pooled sensitivity of 81.2%
for lymph node tissues, 62.8% for CSF, and 21.4% for pleural
ﬂuid and a pooled speciﬁcity of >98.7% against a compos-
ite reference standard.23 Our multiplex PCR targeting IS6110
and MPB64 showed a much higher sensitivity (88.9% for body
ﬂuids, 91.2% for pus/aspirate samples, and 94.4% for tissue
samples) compared with Xpert MTB/RIF assay while the speci-
ﬁcity was lower in our study (85.2% to 88.5%) when CGS was
used as the reference.
The present study has made an attempt to use CGS for
comparative evaluation of multiplex PCR instead of using
only culture positivity as gold standard. The variety of extra-
pulmonary samples included in our study is also an added
advantage in deciding the clinical utility of such assays in
various clinical settings. But the low sample size especially
when individual sample types were analyzed separately is a
limitation of our study.
In summary, the multiplex PCR assay targeting IS6110 and
MPB64 has a great potential to improve the rapid diagnosis of
extrapulmonary tuberculosis. While multiplex PCR detected
M.  tuberculosis in less than a day, the average time to detection
for automated culture was 23.6 days for extrapulmonary sam-
ples in our study. Therefore, the suggested protocol is to use
PCR along with the microbiological methods to obtain a rapid
and accurate diagnosis of TB.Conﬂicts  of  interest
The authors declare no conﬂicts of interest.
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